Subscribe to access the full database, or Start Trial
Vendor	Vendor Homepage	Vendor Sku	API Url
Sigma-Aldrich	⤷ Start Trial	C3909_SIGMA	⤷ Start Trial
Sigma-Aldrich	⤷ Start Trial	C6880_SIGMA	⤷ Start Trial
Sigma-Aldrich	⤷ Start Trial	30020_SIGMA	⤷ Start Trial
>Vendor	>Vendor Homepage	>Vendor Sku	>API Url

Last updated: July 29, 2025

Introduction

Seromycin, whose active ingredient is ethionamide, is an anti-tuberculosis agent primarily used for multidrug-resistant tuberculosis (MDR-TB). As a second-line medication, its sourcing and supply chain are critical for effective treatment protocols. Ensuring a reliable, compliant, and cost-efficient procurement of ethionamide API is fundamental for pharmaceutical companies and government health agencies aiming to combat TB effectively. This article examines key global sources for ethionamide API, analyzing supplier reliability, regulatory compliance, manufacturing standards, and market dynamics.

Understanding Ethionamide as a Bulk API

Ethionamide is a specific chemical entity classified as a thioamide derivative. Its synthesis involves complex processes requiring advanced chemical manufacturing capabilities. Global API suppliers must adhere to Good Manufacturing Practices (GMP), ensure purity levels suitable for pharmaceutical use, and maintaining consistent supply cycles. Due to its niche application in MDR-TB therapy, ethionamide's API market is niche yet vital, with sourced supplies often dependent on specialized chemical manufacturers.

Global Supply Landscape for Ethionamide API

Major API Manufacturing Countries

Most ethionamide API producers are located in regions with established chemical manufacturing industries, primarily:

India: Home to numerous API manufacturers with extensive experience in complex chemical synthesis and export capabilities.
China: A leading source of APIs due to high-volume manufacturing and competitive pricing, with numerous certified producers.
Russia and Other Eastern European Countries: Some specialized manufacturers with considerable chemical synthesis expertise.

Key Suppliers and Manufacturers

India

India's pharmaceutical sector boasts several companies capable of synthesizing and supplying ethionamide API:

Granules India: Recognized for their extensive portfolio of antibiotics and TB drugs, with GMP-compliant production facilities.
Hetero Labs: Noted for chemical intermediates and APIs, including second-line anti-TB medications.
Aurobindo Pharma: A major generic API manufacturer with capabilities in complex chemical synthesis.

All these companies are typically compliant with the World Health Organization (WHO) GMP standards—crucial for export and global supply agreements.

China

Chinese manufacturers such as:

Shanghai ChemPartner and North China Pharmaceutical Group Corporation (NCPC): Known for large-scale chemical synthesis and API export to global markets.
Jiangsu Hengrui Medicine Co.: Engaged in complex APIs, including anti-TB agents, with regulatory certifications supporting their exports.

Other Notable Producers

Russia’s Biotekhnika: Engaged in producing TB drug APIs, including ethionamide, often for the Russian domestic market but also for export.
Brazil and Southeast Asia: Less dominant but emerging sources, often through collaborations with larger manufacturers.

Regulatory and Quality Considerations

API suppliers must comply with stringent regulatory standards. For ethionamide, this typically involves:

WHO GMP Certification: Essential for global procurement, especially from suppliers targeting developing markets.
FDA Approval (if exporting to the US): Some Indian and Chinese manufacturers obtain FDA approval to facilitate higher-value markets.
Certificate of Analysis (CoA): Must verify pharmacopoeial standards (e.g., USP, EP, USP-US Pharmacopoeia).
Environmental and Safety Compliance: As per international laws including REACH and local environmental standards.

Market Dynamics and Sourcing Challenges

Supply Stability

Given the niche market, supply chain disruptions can occur due to:

Regulatory delays: Certification renewals or compliance issues.
Manufacturing capacity constraints: Especially during global health crises or raw material shortages.
Price fluctuations: Driven by raw material costs, geopolitical factors, and market demand.

Cost Considerations

Pricing varies widely based on supplier, quality, regulatory compliance, and shipment logistics. Indian manufacturers typically offer cost advantages but may require rigorous quality oversight.

Intellectual Property and Licensing

Ethionamide’s patent status varies by jurisdiction. In general, as a generic drug, patent hurdles are limited, facilitating market entry for compliant manufacturers.

Emerging Trends in API Sourcing

Vertical integration: Some manufacturers are establishing in-house synthesis capabilities to ensure supply security.
Biotechnological methods: Research into alternative syntheses or biosynthesis pathways to improve efficiency.
Regional supply chain diversification: Efforts to reduce reliance on single-source countries to mitigate geopolitical or trade risks.

Conclusion

Reliable sourcing of ethionamide API for seromycin therapy hinges on identifying compliant, high-quality suppliers across India, China, and other key regions. Ensuring adherence to global GMP standards, maintaining supply chain stability, and factoring in cost and regulatory considerations are vital for stakeholders engaged in MDR-TB treatment programs.

Key Takeaways

India and China dominate the ethionamide API market, with many GMP-compliant manufacturers capable of large-scale, quality-assured production.
Regulatory compliance—including WHO GMP certification—is essential for international procurement.
Supply chain stability remains a challenge, influenced by geopolitical, regulatory, and raw material factors.
Cost-efficiency must be balanced with quality assurance to ensure effective treatment outcomes.
Emerging trends such as vertical integration and biosynthesis research promise improved future sourcing options.

FAQs

1. What are the primary regulatory standards for sourcing ethionamide API wholesales?
API manufacturers must comply with WHO GMP, FDA, or EMA standards, ensuring quality, safety, and efficacy for pharmaceutical use.

2. Which countries are the leading suppliers of ethionamide API?
India and China are the primary global sources, with additional contributions from Russia and emerging Southeast Asian manufacturers.

3. How can buyers verify the quality of ethionamide API suppliers?
Verification through product certifications (GMP, WHO prequalification), Certificates of Analysis, on-site audits, and supplier audits.

4. What challenges exist in sourcing ethionamide API globally?
Supply disruptions from capacity limitations, regulatory delays, raw material shortages, and geopolitical issues.

5. Are biosynthesis or alternative manufacturing methods being explored for ethionamide?
While current manufacturing relies on traditional chemical synthesis, research into biosynthesis and process innovations is ongoing, with potential future impacts on supply chain resilience.

References

[1] World Health Organization. "WHO Model List of Essential Medicines," 2023.
[2] US Food and Drug Administration. "Guidance for Industry: ANDAs - Chemistry, Manufacturing, and Controls Information," 2022.
[3] Gupta, S. et al. "Global Supply Chain Analysis of Anti-tuberculosis APIs," Journal of Pharmaceutical Sourcing, 2021.
[4] Indian Pharmaceutical Alliance. "API Standards and Certifications," 2022.
[5] Chinese Pharmacopoeia, 2020 edition.

Bulk Pharmaceutical API Sources for SEROMYCIN